Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

NCT03549819 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03549819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03549819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Unknown status
Start date
December 15, 2021
Completion date
February 29, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agoraphobia, generalized anxiety disorder, panic disorder, social anxiety disorder